common.study.topics.clinical

Tirzepatide in Participants with Impaired Liver Function

common.study.values.description

“A Study of Tirzepatide in Participants With Impaired Liver Function”

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants. The study will last about two months and will include five visits to the study center.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Tirzepatide

Administered SC

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Single Dose Pharmacokinetic Study of Tirzepatide in Subjects With Varying Degrees of Hepatic Impairment

common.study.values.clinical-trial-id

NCT03940742

participant.views.study.view.id

bo2kYa